PROSTVAC™
PROSTVAC™ is a therapeutic cancer vaccine moving into
late-stage clinical development.
The vaccine has the potential to significantly extend the
lives of men with advanced prostate cancer where limited treatment
options are available - without affecting their quality of
life.
PROSTVAC™ also holds the promise of moving into larger
patient populations in earlier stages of the disease.
PROSTVAC™ is intended for use in patients whose disease
has recurred after surgery or radiotherapy - fulfilling an unmet
medical need.
